JSSH
RPRX icon

J. Safra Sarasin Holding’s Royalty Pharma RPRX Stock Holding History

J. Safra Sarasin Holding’s Portfolio RPRX Stock Details RPRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.66M Buy
30,662
+9,573
+45% +$498K 0.02% 296
2026
Q1 		$1.01M Sell
21,089
-68,946
-77% -$3.02M 0.02% 288
2025
Q4 		$3.48M Buy
+90,035
New +$3.43M 0.06% 155

Other funds holding RPRX

Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

J. Safra Sarasin Holding's RPRX Position: Q2 2026 in Review

J. Safra Sarasin Holding increased its Royalty Pharma (RPRX) stake by 45% in Q2 2026, buying an estimated $498K and bringing the position to 30,662 shares worth $1.66M. The position accounts for 0.02% of the portfolio, ranked #296.

J. Safra Sarasin Holding first reported a position in RPRX in Q4 2025 and has held it in 3 quarters since. The position peaked at $3.48M in Q4 2025. 641 funds tracked by Wall St. Rank hold RPRX as of Q2 2026.

  • J. Safra Sarasin Holding held 30,662 shares of Royalty Pharma worth $1.66M as of Q2 2026.
  • J. Safra Sarasin Holding bought 9,573 Royalty Pharma shares in Q2 2026, an estimated $498K.
  • Royalty Pharma made up 0.02% of J. Safra Sarasin Holding's portfolio in Q2 2026, its #296 holding.
  • J. Safra Sarasin Holding first reported a position in Royalty Pharma in Q4 2025 and has held it in 3 quarters since.
  • J. Safra Sarasin Holding's Royalty Pharma position peaked at $3.48M in Q4 2025.
  • 641 funds tracked by Wall St. Rank held Royalty Pharma as of Q2 2026.

Based on J. Safra Sarasin Holding's 13F filing for Q2 2026, filed 31 Jul 2026.